Headline
The latest stories from AHA Today.
The Department of Health and Human Services’ Health Sector Cybersecurity Coordination Center (HC3) yesterday released a guide to help health care organizations protect their internet-connected devices and networks from Distributed Denial of Service attacks, which can keep providers and patients…
The Food and Drug Administration Friday authorized for emergency use a real-time polymerase chain reaction test to detect mpox (formerly known as monkeypox) in lesion swab specimens from individuals whose health care provider suspects they have the virus
The Office of the National Coordinator for Health Information Technology today announced the first six health information networks that will begin to implement the voluntary Trusted Exchange Framework and Common Agreement, a common set of rules required by the 21st Century Cures Act of 2016 and…
The Centers for Medicare & Medicaid Services should require physician-owned hospitals to report their POH status on the Medicare enrollment application for institutional providers, AHA told the agency today. CMS has proposed removing a question on POH status from the application form (CMS-855A…
Commenting today on the CMS proposed policy and technical changes to the Medicare Advantage program for contract year 2024, AHA voiced strong support for proposals to strengthen MA organization oversight and consumer protections and ensure greater equity between Traditional Medicare and the MA…
Following a Feb. 6 court decision that vacated nationwide the federal government’s revised independent dispute resolution process for determining payment for out-of-network services under the No Surprises Act, the Centers for Medicare & Medicaid Services today instructed certified IDR entities…
AHA is offering for hospitals and health systems a second social media toolkit for February with messages for promoting COVID-19 vaccination and boosters.
A new video from AHA and the Children’s Hospital Association is reminding the public how vaccines and boosters are safe, effective means for preventing pediatric illness from COVID-19, the flu and RSV.
The Food and Drug Administration yesterday revised its recent guidance for outsourcing facilities compounding certain ibuprofen oral suspension products.
Centers for Disease Control and Prevention Director Rochelle Walensky, M.D., has restructured the agency to better respond to COVID-19 and other public health threats, Health and Human Services Secretary Xavier Becerra announced.